Immunological Remission as a Basis for Dose Reduction of Immunosuppressors in Autoimmune Hepatitis: Results of Monocenter Surveillance Study
Aim of the study: evaluate the role of normalization of humoral immunity to address dose reduction or discontinuation of immunosuppressors in patients with autoimmune hepatitis (AIH).Patients and methods. The data of 47 patients with AIH who received immunosuppressive therapy from April 2001 to Augu...
Saved in:
Main Authors: | A. O. Bueverov, S. V. Koblov, P. O. Bogomolov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2024-03-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/920 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insulin autoimmune syndrome in a 3-year-old boy: the youngest to date in China and a narrow review
by: Ming Cheng, et al.
Published: (2025-02-01) -
Autoimmune hepatitis with abnormally high level of serum alpha-fetoprotein (Clinical case)
by: A. O. Bueverov, et al.
Published: (2010-02-01) -
The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae
by: Fang He, et al.
Published: (2025-02-01) -
Development of machine learning models for predicting non-remission in early RA highlights the robust predictive importance of the RAID score-evidence from the ARCTIC study
by: Gaoyang Li, et al.
Published: (2025-02-01) -
The effect of rehabilitation on remission following detoxification treatment in alcohol and substance use disorders: A pilot study
by: Mustafa Danisman, et al.
Published: (2024-04-01)